Counterfeit Drugs Harm Real People

We're Collecting Their Stories

Protecting the safety of America's drug supply is about protecting human life. When we compromise the security of America's drug supply, we endanger patients. Sometimes people forget that these policy debates affect real people, but we at PSM never do.

Below you will find the stories of patients and family members that have been victims of a weakened drug supply chain. 
 Note: The patients and family members who appear on this page have not been compensated by PSM for appearing here.
Excerpt of Maxine Blount's Obituary, St. Louis Post-Dispatch, October 28, 2002

Missouri Businesswoman Dies After Fake Anemia Drugs Delay Cancer Treatments

January 1, 2012

In March 2002, oncology nurses in Missouri at discovered that their patient, Maxine Blount, had been taking Procrit that was only one-twentieth the strength it should have been. The counterfeit did not treat her anemia, leading to delays between chemotherapy infusions that allowed her cancer to advance much more rapidly. She died in October 2002.

In 2005, her brother testified before Congress: if her drugs had been genuine “she would have lived longer…experienced much less pain and suffering, and have been able to spend more time with her family.”